Leal Therapeutics develops novel therapeutics for patients.
Leal Therapeutics has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in August 2025.
Leal Therapeutics's investors include OrbiMed, Dementia Discovery Fund, Newpath Management, Alexandria Venture Investments, Euclidean Capital.
Leal Therapeutics is headquartered in Worcester, United States.
Leal Therapeutics develops novel therapeutics for patients.
Leal Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Leal Therapeutics — Funding & Investors." VCBacked, August 27, 2025, https://www.vcbacked.co/company/leal-therapeutics. Accessed July 25, 2026.
VCBacked. (2025). Leal Therapeutics — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/leal-therapeutics
{{cite web |title=Leal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/leal-therapeutics |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated